- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01658111
Robot-aided Therapy in Stroke Patients for Upper Limb Rehabilitation (MITEEG)
Robot-aided Therapy in Acute Stroke Patients for the Upper Limb Rehabilitation With Long-term Follow-up.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main original contribution of this project is to provide an experimental framework, based on proximal robotic treatment approach, to test whether starting with the distal robot-assisted sensorimotor therapy the effective in improving motor functions of sub-acute stroke patients.
The use of robotic platforms to administer the rehabilitation therapy is crucial for two main reasons:
- the physical therapies based on robotic platforms assure that each patient in the same testing group is treated in the same repeatable way, eliminating the intrinsic subject-dependent variability that affects traditional therapies;
- the robotic platforms, in conjunction with EEG and EMG recordings, can be used to assess the effects of the rehabilitative treatments in a quantitative, measurable way, by providing reliable and objective methods for measuring functional recovery after stroke.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Roma, Italy, 00161
- IRCCS San Raffaele Roma
-
Volterra, Italy
- Auxilium Viate Volterra
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- first acute event of cerebrovascular stroke
- unilateral paresis,
- ability to understand and follow simple instructions,
- ability to remain in a sitting posture, even through seat belts for trunk fixation.
Exclusion Criteria:
- bilateral impairment,
- severe sensory deficits in the paretic upper limb,
- cognitive impairment or behavioral dysfunction that would influence the ability to comprehend or perform the experiment,
- refusal or inability to provide informed consent
- other current severe medical problems.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Traditional physiotherapy
Each subject will receive 4 weeks of traditional upper limb rehabilitation treatment (20 sessions, 5 days a week for 4 weeks).
|
Active or passive exercises.
Other Names:
|
Experimental: Robot Group
Each subject will be asked to perform five sessions per week goal-directed, planar reaching tasks, which emphasizes shoulder and elbow movements, moving from the centre target to each of 8 peripheral targets equally spaced on a 0.14 m radius circumference around a centre target using the InMotion2 (IM2) system (20 sessions- 5 days a week for 4 weeks).
|
The MIT-MANUS/InMotion2 (Interactive Motion Technologies, Inc., Watertown, MA, USA) system has two translational degrees of freedom (dof): shoulder abduction-adduction (ab-ad), elbow flexion-extension (flexext). The robotic system supports the execution of reaching movements in the horizontal plane through an assist as needed control strategy. The robot can guide the movement of the upper limb of the patients and record end-effector physical quantities such as the position, velocity, and applied forces. The device is designed to have a low intrinsic end-point impedance (i.e., be back-drivable to easily carry the weight of the patient's arm, to execute movements without constraint and offer minimal resistance. A 3-dof force transducer is placed at the robots end-effector, as well.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from Baseline in Fugl-Meyer Scale at 28 weeks.
Time Frame: at inclusion, week 4 and week 28
|
at inclusion, week 4 and week 28
|
Change from Baseline in Box and Block Test at 28 weeks.
Time Frame: at inclusion, week 4 and week 28.
|
at inclusion, week 4 and week 28.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from Baseline in Modified Ashworth Scale at 28 weeks.
Time Frame: at inclusion, week 4 and week 28.
|
at inclusion, week 4 and week 28.
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from Baseline in Frenchay Arm Test at 28 weeks.
Time Frame: at inclusion, week 4 and week 28.
|
at inclusion, week 4 and week 28.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michela Goffredo, BME, IRCCS San Raffaele Rome
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MIT02012EEG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamActive, not recruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationActive, not recruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Traditional physiotherapy
-
Region ÖstergötlandLinkoeping UniversityNot yet recruitingShoulder Pain | Subacromial Pain Syndrome | Rotator Cuff SyndromeSweden
-
Acibadem UniversityRecruitingChronic Nonspecific Low Back PainTurkey
-
Cairo UniversityRecruiting
-
Jose Manuel Pastora BernalUniversity of Malaga; Hospital Costa del SolUnknownShoulder Impingement SyndromeSpain
-
Hacettepe UniversityCompletedSpastic Hemiplegic Cerebral PalsyTurkey
-
Töölö HospitalRecruitingOrthopedic Procedures, Physical Therapy Modalities, Postoperative Care, Rehabilitation, Wrist FracturesFinland
-
Hacettepe UniversityCompleted
-
University of MalagaCompletedMuscular Dystrophy, Duchenne and Becker TypesSpain
-
University of NicosiaRecruiting
-
İSMAİL CEYLANCompleted